retatrutide week 1 VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide 50mg | High Potency

Adherence to GLP-1 RA therapy may be improved by slowing dose escalation, as per label instructions, and setting patient expectations for possible gastrointestinal adverse outcomes that should subside over time

Mounjaro EPAR Product Information (INN: tirzepatide)

If you have not yet explored the comparison between semaglutide vs tirzepatide vs retatrutide , this mid-treatment window is where the differences become most apparent

If you notice a consistent upward trend of more than 5 lb, step the dose back up to where you were stable

Red flag is useful shorthand in deal memos, but institutional investors need numbers